The FDA De Novo pathway provides a regulatory process for novel medical devices that are found to be low to moderate risk and lack an appropriate predicate device. Acceptance of the company’s De Novo ...

Interrupting DOAC therapy before surgery can increase the risk for thrombotic events, whereas continuing these medications can increase bleeding risk. Clinicians should adopt a balanced and ...

They may have multiple comorbidities and are often medically unstable; treatment must balance the need to prevent ischemic post-procedure ... of mortality and risk of further bleeding.

An inquest in North London heard part of the device used in the biopsy went outside the liver, causing bleeding in the ...

Because these products inhibit at least one, and often multiple, factors in the clotting cascade, patients have an increased risk of bleeding with invasive procedures. Patients also have an ...

Colorado already has one of the most permissive abortion laws in the country. This amendment would not only remove ...

PRINCETON, N.J., Oct. 17, 2024 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery ...

About three months ago, I bled a bit while urinating. This was the first (and only) time in over 30 years that this happened ...

The 2023-2024 Patient Safety Award and Grant centered on fall prevention, which is one of Lafayette Surgical Specialty ...

A new study published in the journal of Obesity Surgery showed that after revisional Roux-en-Y gastric bypass (RYGB), the ...